Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGS) Intangibles: 2022-2025

Historic Intangibles for GeneDx Holdings (WGS) over the last 4 years, with Sep 2025 value amounting to $172.6 million.

  • GeneDx Holdings' Intangibles rose 6.46% to $172.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $172.6 million, marking a year-over-year increase of 6.46%. This contributed to the annual value of $158.6 million for FY2024, which is 8.12% down from last year.
  • According to the latest figures from Q3 2025, GeneDx Holdings' Intangibles is $172.6 million, which was down 2.32% from $176.7 million recorded in Q2 2025.
  • GeneDx Holdings' Intangibles' 5-year high stood at $193.7 million during Q2 2022, with a 5-year trough of $155.1 million in Q1 2025.
  • Over the past 3 years, GeneDx Holdings' median Intangibles value was $172.6 million (recorded in 2025), while the average stood at $170.1 million.
  • Over the last 5 years, GeneDx Holdings' Intangibles had its largest YoY gain of 6.69% in 2025, and its largest YoY loss of 8.29% in 2025.
  • Over the past 4 years, GeneDx Holdings' Intangibles (Quarterly) stood at $186.7 million in 2022, then fell by 7.51% to $172.6 million in 2023, then decreased by 8.12% to $158.6 million in 2024, then rose by 6.46% to $172.6 million in 2025.
  • Its Intangibles was $172.6 million in Q3 2025, compared to $176.7 million in Q2 2025 and $155.1 million in Q1 2025.